Compounds > diethylamine salicylate
Page last updated: 2024-12-11

diethylamine salicylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9837223
SCHEMBL ID1070298
MeSH IDM0086284

Synonyms (18)

Synonym
diethylamine salicylate
4419-92-5
diethylammonium salicylate
FT-0624875
diethylamine salicylate [who-dd]
diethylamine salicylate [mart.]
SCHEMBL1070298
diethylamine 2-hydroxybenzoate
AKOS027382454
D81871
n-ethylethanamine;2-hydroxybenzoic acid
DS-14103
DTXSID20963183
2-hydroxybenzoic acid--n-ethylethanamine (1/1)
Q27262917
A855543
SB78772
CS-0187365
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.81 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index78.27 (26.88)
Search Engine Supply Index2.30 (0.95)

This Compound (46.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
salicylic acid
Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).		2.0110monohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
salicylamide
salamide: a major impurity of hydrochlorothiazide; structure in first source		2.4220phenols;
salicylamides		antirheumatic drug;
non-narcotic analgesic
beta-escin
Escin: Pentacyclic triterpene saponins, biosynthesized from protoaescigenin and barringtogenol, occurring in the seeds of AESCULUS. It inhibits edema formation and decreases vascular fragility.		3.3911triterpenoid saponin
salicylates
Salicylates: The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.. hydroxybenzoate : Any benzoate derivative carrying a single carboxylate group and at least one hydroxy substituent.. salicylates : Any salt or ester arising from reaction of the carboxy group of salicylic acid, or any ester resulting from the condensation of the phenolic hydroxy group of salicylic acid with an organic acid.. salicylate : A monohydroxybenzoate that is the conjugate base of salicylic acid.		4.661monohydroxybenzoateplant metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Itching
[description not available]		02.0110
Pruritus
An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.		02.0110
Rheumatism
[description not available]		02.3420
Rheumatic Diseases
Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.		02.3420
Musculoskeletal Pain
Discomfort stemming from muscles, LIGAMENTS, tendons, and bones.		01.9310
Athletic Injuries
Injuries incurred during participation in competitive or non-competitive sports.		03.3911
Ache
[description not available]		03.7621
Arm Injuries
General or unspecified injuries involving the UPPER ARM and the FOREARM.		03.3911
Blunt Injuries
[description not available]		08.3911
Injuries, Leg
[description not available]		03.3911
Pain
An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.		03.7621